Decision/Risk Analysis · Cambridge, MA · Founded 2021 · Privately Held (backing)
Developer of an AI-driven medical technology designed to enhance early diagnosis and intervention in cardiovascular care. Anumana is based in Cambridge, MA and was founded in 2021. It was valued at $580 million at its early-stage round in Mar 2025, the last priced event on record. It has raised $185 million across 3 recorded rounds; the latest was a $95.4 million early-stage round in Mar 2025.
PMV mark · valuation
$580.0M
Oct 2026
Priced at
its early-stage round
Mar 2025
Total raised
$185.3M
Last round
Early Stage VC
Mar 2025
Cap table — not yet on record
Anumana's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Anumana with a free account
·Watch Anumana: the Monday email on marks, rounds and moves